Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
Identifieur interne : 000246 ( Istex/Curation ); précédent : 000245; suivant : 000247Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
Auteurs : Sam Birdi [Canada] ; Ali H. Rajput [Canada] ; Mark Fenton [Canada] ; Jeffery R. Donat [Canada] ; Bohdan Rozdilsky [Canada] ; Christopher Robinson [Canada] ; Rob Macaulay [Canada] ; David George [Canada]Source :
- Movement Disorders [ 0885-3185 ] ; 2002-11.
English descriptors
Abstract
We evaluated 16 (15 men, 1 woman) autopsy‐verified progressive supranuclear palsy (PSP) cases during 31 years (1969–2000) for clinical diagnosis and the course of the disease. The onset was gait difficulty or postural instability in 9 (56.3%), general motor slowing in 3 (18.8%), and tremor in 2. One case had onset with cognitive decline and 1 as hemidystonia. Four cases had supranuclear ophthalmoplegia (SNO) at the first assessment and were diagnosed as PSP. By last assessment, PSP diagnosis was made in 4 additional cases, but in 8 (50%) who never manifested ophthalmoplegia (mean 9.8 years after onset), PSP diagnosis was not made. Other manifestations included bulbar symptoms in 13 (81.3%), and cognitive impairment in 10 (62.5%) during the course of illness. Fifteen cases received levodopa, amantadine, anticholinergics, dopamine agonists, and selegiline in different combinations with symptomatic benefit in 9 of 15 (60%). Five had some improvement on levodopa alone and 3 showed more improvement when a dopamine agonist was added to levodopa. In general, the benefit was minimal and occurred only early in the course of illness. The mean age at onset was 63.7 (range, 53–85) years. Mean duration at PSP diagnosis was 4.8 (range, 2–11) years. Mean survival was 8.6 (range, 3–24) years and mean age at death was 72.3 (range, 60–89) years. When the different diagnostic criteria recommended in the literature were used, the accuracy of clinical diagnosis did not improve substantially. © 2002 Movement Disorder Society
Url:
DOI: 10.1002/mds.10211
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000246
Links to Exploration step
ISTEX:D1EE5808C9DB03F2371033F27730FFC47B3F2AD2Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases</title><author><name sortKey="Birdi, Sam" sort="Birdi, Sam" uniqKey="Birdi S" first="Sam" last="Birdi">Sam Birdi</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Rajput, Ali H" sort="Rajput, Ali H" uniqKey="Rajput A" first="Ali H." last="Rajput">Ali H. Rajput</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Fenton, Mark" sort="Fenton, Mark" uniqKey="Fenton M" first="Mark" last="Fenton">Mark Fenton</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Donat, Jeffery R" sort="Donat, Jeffery R" uniqKey="Donat J" first="Jeffery R." last="Donat">Jeffery R. Donat</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Rozdilsky, Bohdan" sort="Rozdilsky, Bohdan" uniqKey="Rozdilsky B" first="Bohdan" last="Rozdilsky">Bohdan Rozdilsky</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Robinson, Christopher" sort="Robinson, Christopher" uniqKey="Robinson C" first="Christopher" last="Robinson">Christopher Robinson</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Macaulay, Rob" sort="Macaulay, Rob" uniqKey="Macaulay R" first="Rob" last="Macaulay">Rob Macaulay</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Dalhousie, Halifax, Nova Scotia, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Dalhousie, Halifax, Nova Scotia</wicri:regionArea></affiliation></author><author><name sortKey="George, David" sort="George, David" uniqKey="George D" first="David" last="George">David George</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Calgary, Calgary, Alberta, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:D1EE5808C9DB03F2371033F27730FFC47B3F2AD2</idno><date when="2002" year="2002">2002</date><idno type="doi">10.1002/mds.10211</idno><idno type="url">https://api.istex.fr/document/D1EE5808C9DB03F2371033F27730FFC47B3F2AD2/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">000246</idno><idno type="wicri:Area/Istex/Curation">000246</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases</title><author><name sortKey="Birdi, Sam" sort="Birdi, Sam" uniqKey="Birdi S" first="Sam" last="Birdi">Sam Birdi</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Rajput, Ali H" sort="Rajput, Ali H" uniqKey="Rajput A" first="Ali H." last="Rajput">Ali H. Rajput</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Fenton, Mark" sort="Fenton, Mark" uniqKey="Fenton M" first="Mark" last="Fenton">Mark Fenton</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Donat, Jeffery R" sort="Donat, Jeffery R" uniqKey="Donat J" first="Jeffery R." last="Donat">Jeffery R. Donat</name><affiliation wicri:level="1"><mods:affiliation>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Division of Neurology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Rozdilsky, Bohdan" sort="Rozdilsky, Bohdan" uniqKey="Rozdilsky B" first="Bohdan" last="Rozdilsky">Bohdan Rozdilsky</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Robinson, Christopher" sort="Robinson, Christopher" uniqKey="Robinson C" first="Christopher" last="Robinson">Christopher Robinson</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Saskatchewan, Saskatoon, Saskatchewan</wicri:regionArea></affiliation></author><author><name sortKey="Macaulay, Rob" sort="Macaulay, Rob" uniqKey="Macaulay R" first="Rob" last="Macaulay">Rob Macaulay</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Dalhousie, Halifax, Nova Scotia, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Dalhousie, Halifax, Nova Scotia</wicri:regionArea></affiliation></author><author><name sortKey="George, David" sort="George, David" uniqKey="George D" first="David" last="George">David George</name><affiliation wicri:level="1"><mods:affiliation>Department of Pathology, University of Calgary, Calgary, Alberta, Canada</mods:affiliation><country xml:lang="fr">Canada</country><wicri:regionArea>Department of Pathology, University of Calgary, Calgary, Alberta</wicri:regionArea></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="sub">Official Journal of the Movement Disorder Society</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>New York</pubPlace><date type="published" when="2002-11">2002-11</date><biblScope unit="vol">17</biblScope><biblScope unit="issue">6</biblScope><biblScope unit="page" from="1255">1255</biblScope><biblScope unit="page" to="1264">1264</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">D1EE5808C9DB03F2371033F27730FFC47B3F2AD2</idno><idno type="DOI">10.1002/mds.10211</idno><idno type="ArticleID">MDS10211</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>diagnosis</term><term>levodopa treatment</term><term>prognosis</term><term>progressive supranuclear palsy</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We evaluated 16 (15 men, 1 woman) autopsy‐verified progressive supranuclear palsy (PSP) cases during 31 years (1969–2000) for clinical diagnosis and the course of the disease. The onset was gait difficulty or postural instability in 9 (56.3%), general motor slowing in 3 (18.8%), and tremor in 2. One case had onset with cognitive decline and 1 as hemidystonia. Four cases had supranuclear ophthalmoplegia (SNO) at the first assessment and were diagnosed as PSP. By last assessment, PSP diagnosis was made in 4 additional cases, but in 8 (50%) who never manifested ophthalmoplegia (mean 9.8 years after onset), PSP diagnosis was not made. Other manifestations included bulbar symptoms in 13 (81.3%), and cognitive impairment in 10 (62.5%) during the course of illness. Fifteen cases received levodopa, amantadine, anticholinergics, dopamine agonists, and selegiline in different combinations with symptomatic benefit in 9 of 15 (60%). Five had some improvement on levodopa alone and 3 showed more improvement when a dopamine agonist was added to levodopa. In general, the benefit was minimal and occurred only early in the course of illness. The mean age at onset was 63.7 (range, 53–85) years. Mean duration at PSP diagnosis was 4.8 (range, 2–11) years. Mean survival was 8.6 (range, 3–24) years and mean age at death was 72.3 (range, 60–89) years. When the different diagnostic criteria recommended in the literature were used, the accuracy of clinical diagnosis did not improve substantially. © 2002 Movement Disorder Society</div></front></TEI></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000246 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd -nk 000246 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Istex
|étape= Curation
|type= RBID
|clé= ISTEX:D1EE5808C9DB03F2371033F27730FFC47B3F2AD2
|texte= Progressive supranuclear palsy diagnosis and confounding features: Report on 16 autopsied cases
}}
| This area was generated with Dilib version V0.6.23. |  |